ONRAB is a rabies glycoprotein recombinant human adenovirus type 5 oral vaccine developed for application in baits to control rabies in wildlife populations. Prior to widespread use of ONRAB, both the safety and effectiveness of this vaccine required investigation. While previous research has focused on field performance and the persistence and pathogenicity of ONRAB in captive animals, we sought to examine persistence and shedding of ONRAB in populations of free-ranging target and non-target mammals. We collected oral and rectal swab samples from 84 red foxes, 169 striped skunks, and 116 raccoons during 2007 and 2008 in areas where ONRAB vaccine baits were distributed. We also analyzed 930 tissue samples, 135 oral swab and 138 rectal swab samples from 155 non-target small mammals from 10 species captured during 2008 at sites treated with high densities of ONRAB vaccine baits. Samples were screened for the presence and quantity of ONRAB DNA using quantitative real-time PCR. None of the samples that we analyzed from target and non-target species contained quantities of ONRAB greater than 10(3)EU/mL of ONRAB DNA which is a limit that has previously been applied to assess viral shedding. This study builds on similar research and suggests that replication of ONRAB in animals is short-lived and the likelihood of horizontal transmission to other organisms is low.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.vaccine.2013.02.057 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Oral Rabies Vaccination of Raccoons (Procyon lotor) across a Development Intensity Gradient in Burlington, Vermont, USA, 2015-2017.
J Wildl Dis
January 2024
United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center, 4101 Laporte Avenue, Fort Collins, Colorado 80521, USA.
Management of the raccoon rabies virus variant in North America is conducted primarily using oral rabies vaccination (ORV). When a sufficient proportion of the population is vaccinated (∼60%), rabies transmission can be eliminated. To date, ORV programs have successfully controlled and eliminated raccoon rabies in rural areas, but there has been less success in urban areas.
View Article and Find Full Text PDFOral Rabies Vaccination of Small Indian Mongooses () with ONRAB via Ultralite Baits.
Viruses
April 2021
United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center, 4101 LaPorte Ave., Fort Collins, CO 80521, USA.
Article Synopsis
- The Ontario Rabies Vaccine (ONRAB) is a recombinant oral vaccine effective in immunizing small Indian mongooses through direct oral delivery using Ultralite baits.
- In a study with 24 mongooses, 18 received the ONRAB vaccine while 6 received a placebo, with researchers measuring the presence of rabies virus neutralizing antibodies (RVNA) over 30 days.
- Results showed that 84.6% of mongooses that consumed the vaccine bait developed RVNA, while those that received the placebo remained negative, indicating ONRAB's potential effectiveness but suggesting the need for better bait design.
Serological Responses of Raccoons and Striped Skunks to Ontario Rabies Vaccine Bait in West Virginia during 2012-2016.
Viruses
January 2021
USDA/APHIS/WS/National Rabies Management Program, 59 Chenell Dr., Concord, NH 03301, USA.
Since the 1990s, oral rabies vaccination (ORV) has been used successfully to halt the westward spread of the raccoon rabies virus (RV) variant from the eastern continental USA. Elimination of raccoon RV from the eastern USA has proven challenging across targeted raccoon () and striped skunk () populations impacted by raccoon RV. Field trial evaluations of the Ontario Rabies Vaccine Bait (ONRAB) were initiated to expand ORV products available to meet the rabies management goal of raccoon RV elimination.
View Article and Find Full Text PDFRabies Surveillance Identifies Potential Risk Corridors and Enables Management Evaluation.
Viruses
October 2019
National Wildlife Research Center, United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, Fort Collins, CO 80521, USA.
Intensive efforts are being made to eliminate the raccoon variant of rabies virus (RABV) from the eastern United States and Canada. The United States Department of Agriculture (USDA) Wildlife Services National Rabies Management Program has implemented enhanced rabies surveillance (ERS) to improve case detection across the extent of the raccoon oral rabies vaccination (ORV) management area. We evaluated ERS and public health surveillance data from 2006 to 2017 in three northeastern USA states using a dynamic occupancy modeling approach.
View Article and Find Full Text PDFImmunogenicity of Ontario Rabies Vaccine for Small Indian Mongooses ().
J Wildl Dis
January 2020
US Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center, 4101 LaPorte Ave., Fort Collins, Colorado 80521, USA.
Article Synopsis
- Oral rabies vaccination is crucial for controlling rabies in wildlife, but no vaccine is currently licensed for small Indian mongooses.
- The ONRAB vaccine, tested on mongooses in this study, showed promising results, with 87% of vaccinated animals developing rabies virus neutralizing antibodies by 14 days post-vaccination.
- While the vaccine dose had a marginal effect on antibody levels at 14 days, all vaccinated mongooses had detectable antibodies by 30 days, and control animals remained seronegative throughout the study.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!